| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $93.2M | +288.0% |
| Cost of Revenue | $21.6M | -9.6% |
| Gross Profit | $71.7M | — |
| R&D Expense | $8.8M | +96.7% |
| SG&A Expense | $53.1M | +21.0% |
| Operating Income | -$5.0M | +92.3% |
| Pre-tax Income | -$5.4M | +91.7% |
| Income Tax | -$1.1M | -101.6% |
| Net Income | -$4.2M | +96.9% |
| EPS (Basic) | -$0.04 | +96.5% |
| EPS (Diluted) | -$0.04 | +96.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $176.6M | -27.4% |
| Accounts Receivable | $3.7M | -27.7% |
| Current Assets | $222.7M | -19.2% |
| Total Assets | $236.7M | -20.1% |
| Current Liabilities | $49.3M | +4.2% |
| Long-term Debt | $84.8M | -39.3% |
| Total Liabilities | $161.7M | -25.9% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.2M | -118.1% |
| Capital Expenditures | $56K | -66.1% |
| Investing Cash Flow | -$1.0M | +73.6% |
| Financing Cash Flow | -$61.5M | -853.7% |
| Free Cash Flow | -$3.3M | -118.6% |
| $75.0M |
| -4.0% |